79
Views
4
CrossRef citations to date
0
Altmetric
Reviews

Association of IL-6 -176G > C Polymorphism with Susceptibility to Preeclampsia: A Systematic Review and Meta-Analysis

, , , , , , , , & show all
Pages 491-502 | Received 27 Aug 2019, Accepted 17 Sep 2019, Published online: 18 Nov 2019

References

  • Serrano NC, Casas JP, Díaz LA, Páez C, Mesa CM, Cifuentes R, Monterrosa A, Bautista A, Hawe E, Hingorani AD, et al. Endothelial NO synthase genotype and risk of preeclampsia: a multicenter case-control study. Hypertension. 2004;44:702–7. doi:10.1161/01.HYP.0000143483.66701.ec.
  • Sowmya S, Ramaiah A, Nallari P, Jyothy A, Venkateshwari A. Role of IL-6 -174(G/C) promoter polymorphism in the etiology of early-onset preeclampsia. Inflamm Res. 2015;64:433–9. doi:10.1007/s00011-015-0823-z.
  • Townsend R, O’Brien P, Khalil A. Current best practice in the management of hypertensive disorders in pregnancy. Integr Blood Press Control. 2016;9:79–94. doi:10.2147/IBPC.S77344.
  • Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10:466–80. doi:10.1038/nrneph.2014.102.
  • Gupte S, Wagh G. Preeclampsia-eclampsia. J Obstet Gynecol India. 2014;64:4–13. doi:10.1007/s13224-014-0502-y.
  • Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M, Vogel JP, Souza JP, WHO Multicountry Survey on Maternal and Newborn Health Research Network. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014;121:14–24. doi:10.1111/1471-0528.12629.
  • Trogstad L, Magnus P, Stoltenberg C. Pre-eclampsia: risk factors and causal models. Best Pract Res Clin Obstet Gynaecol. 2011;25:329–42. doi:10.1016/j.bpobgyn.2011.01.007.
  • Williams PJ, Morgan L. The role of genetics in pre-eclampsia and potential pharmacogenomic interventions. Pharmacogenomics Pers Med. 2012;5:37–51. doi:10.2147/PGPM.S23141.
  • Xu L, Lee M, Jeyabalan A, Roberts JM. The relationship of hypovitaminosis D and IL-6 in preeclampsia. Am J Obstet Gynecol. 2014;210:149.e1–7. doi:10.1016/j.ajog.2013.09.037.
  • Chang L, Lan T, Wu L, Li C, Yuan Y, Liu Z. The association between three IL-6 polymorphisms and HBV-related liver diseases: a meta-analysis. Int J Clin Exp Med. 2015;8:17036–45.
  • Salimi E, Karimi-Zarchi M, Dastgheib SA, Abbasi H, Tabatabaiee RS, Hadadan A, Amjadi N, Akbarian-Bafghi MJ, Neamatzadeh H. Association of promoter region polymorphisms of IL-6 and IL-18 genes with risk of recurrent pregnancy loss: a systematic review and meta-analysis. Fetal Pediatr Pathol. 2019;1–14. doi:10.1080/15513815.2019.1652379. [Epub ahead of print].
  • Sheikhpour E, Noorbakhsh P, Foroughi E, Farahnak S, Nasiri R, Neamatzadeh H. A survey on the role of interleukin-10 in breast cancer: a narrative. Rep Biochem Mol Biol. 2018;7:30–7.
  • Miranda-Vilel AL, Ribeiro IF, Grisolia CK. Association between interleukin 6 -174 G/C promoter gene polymorphism and runners’ responses to the dietary ingestion of antioxidant supplementation based on pequi (Caryocar brasiliense camb.) oil: a before-after study. Genet Mol Biol. 2016;39:554–66. doi:10.1590/1678-4685-gmb-2015-0299.
  • Saarela T, Hiltunen M, Helisalmi S, Heinonen S, Laakso M. Polymorphisms of interleukin-6, hepatic lipase and calpain-10 genes, and preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2006;128:175–9. doi:10.1016/j.ejogrb.2005.12.015.
  • Fan DM, Wang Y, Liu XL, Zhang A, Xu Q. Polymorphisms in interleukin-6 and interleukin-10 may be associated with risk of preeclampsia. Genet Mol Res. 2017;16(1). doi:10.4238/gmr16018588.
  • Stonek F, Metzenbauer M, Hafner E, Philipp K, Tempfer C. Interleukin 6-174 G/C promoter polymorphism and pregnancy complications: results of a prospective cohort study in 1626 pregnant women. Am J Reprod Immunol. 2008;59:347–51. doi:10.1111/j.1600-0897.2007.00577.x.
  • Stonek F, Hafner E, Metzenbauer M, Katharina S, Stümpflen I, Schneeberger C, Zeisler H, Husslein P, Philipp K. Absence of an association of tumor necrosis factor (TNF)-alpha G308A, interleukin-6 (IL-6) G174C and interleukin-10 (IL-10) G1082A polymorphism in women with preeclampsia. J Reprod Immunol. 2008;77:85–90. doi:10.1016/j.jri.2007.04.003.
  • de Lima THB, Sass N, Mattar R, Moron AF, Torloni MR, Franchim CS, Daher S. Cytokine gene polymorphisms in preeclampsia and eclampsia. Hypertens Res. 2009;32:565–9. doi:10.1038/hr.2009.58.
  • Valencia Villalvazo EY, Canto-Cetina T, Romero Arauz JF, Coral-Vázquez RM, Canizales-Quinteros S, Coronel A, Carlos Falcón J, Hernández Rivera J, Ibarra R, Polanco Reyes L, et al. Analysis of polymorphisms in interleukin-10, interleukin-6, and interleukin-1 receptor antagonist in Mexican-Mestizo women with pre-eclampsia. Genet Test Mol Biomarkers. 2012;16:1263–69. doi:10.1089/gtmb.2012.0181.
  • Vural P, Degirmencioglu S, Saral NY, Demirkan A, Akgul C, Yildirim G, Issever H, Eroglu H. Tumor necrosis factor α, interleukin-6 and interleukin-10 polymorphisms in preeclampsia. J Obstet Gynaecol Res. 2010;36:64–71. doi:10.1111/j.1447-0756.2009.01111.x.
  • Freeman DJ, McManus F, Brown EA, Cherry L, Norrie J, Ramsay JE, Clark P, Walker ID, Sattar N, Greer IA, et al. Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension. 2004;44:708–14. doi:10.1161/01.HYP.0000143849.67254.ca.
  • Pinheiro MB, Gomes KB, Ronda CRSC, Guimarães GG, Freitas LG, Teixeira-Carvalho A, Martins-Filho OA, Dusse LM. Severe preeclampsia: association of genes polymorphisms and maternal cytokines production in Brazilian population. Cytokine. 2015;71:232–7. doi:10.1016/j.cyto.2014.10.021.
  • Puppala M, Veerathu LK, Argi A, Godi S, Polipalli SK. AB032. Cytokines gene polymorphism in pregnant women at a risk of preeclampsia. Ann Transl Med. 2017;5:AB032. doi:10.21037/atm.2017.s032.
  • Xie C, Yao MZ, Liu JB, Xiong LK. A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia. Cytokine. 2011;56:550–9. doi:10.1016/j.cyto.2011.09.021.
  • Yazdi MM, Jamalaldini MH, Sobhan MR, Jafari M, Mazaheri M, Zare-Shehneh M, Neamatzadeh H. Association of ESRα gene Pvu II T > C, XbaI A > G and BtgI G > A polymorphisms with knee osteoarthritis susceptibility: a systematic review and meta-analysis based on 22 case-control studies. Arch Bone Jt Surg. 2017;5:351–62. doi:10.22038/abjs.2017.22391.1578.
  • Namazi A, Forat-Yazdi M, Jafari M, Farahnak S, Nasiri R, Foroughi E, Abolbaghaei SM, Neamatzadeh H. Association of interleukin-10 -1082 A/G (rs1800896) polymorphism with susceptibility to gastric cancer: meta-analysis of 6,101 cases and 8,557 controls. Arq Gastroenterol. 2018;55:33–40. doi:10.1590/s0004-2803.201800000-18.
  • Kamali M, Kargar S, Heiranizadeh N, Zare M, Kargar S, Shehneh MZ, Neamatzadeh H. Lack of any association between the hoGG1 Ser326Cys polymorphism and breast cancer risk: a systematic review and meta-analysis of 18 studies. Asian Pac J Cancer Prev. 2017;18:245–51. doi:10.22034/APJCP.2017.18.1.245.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.